Evolus (EOLS) Total Debt (2017 - 2026)
Evolus (EOLS) reported Total Debt of $156.4 million for Q1 2026, up 28.41% on a YoY basis from $121.8 million in Q1 2025, and up 7.06% quarter-over-quarter from $146.1 million in Q4 2025.
Evolus (EOLS) Total Debt (2017 - 2026) Analysis & Trends
Evolus has reported Total Debt for 10 years, with the latest figure at $156.4 million in Q1 2026.
- For the quarter ending Q1 2026, Total Debt rose 28.41% year-over-year to $156.4 million; the trailing twelve-month figure through Mar 2026 stood at $156.4 million (up 28.41% YoY), and the FY2025 full-year result was $146.1 million, up 20.24% from the prior year.
- Total Debt for Q1 2026 stood at $156.4 million, up from $146.1 million in the prior quarter.
- The five-year high for Total Debt was $156.4 million in Q1 2026, with the low at $71.4 million in Q1 2022.
- Historically, Total Debt has averaged $109.9 million across 5 years, with a median of $120.6 million in 2024.
- Annual changes were most pronounced in 2022 — Total Debt advanced 0.92% — and 2023, when it soared 67.45%.
- Evolus' Total Debt stood at $71.9 million in 2022, then surged by 67.45% to $120.4 million in 2023, then grew by 0.95% to $121.5 million in 2024, then rose by 20.24% to $146.1 million in 2025, then increased by 7.06% to $156.4 million in 2026.
- The last three Total Debt figures came in at $156.4 million (Q1 2026), $146.1 million (Q4 2025), and $145.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.63 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.53 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.99 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.51 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 570.41 Mn |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn | 156.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156.41 Mn |
| Dec 31, 2025 | 146.10 Mn |
| Sep 30, 2025 | 145.78 Mn |
| Jun 30, 2025 | 145.48 Mn |
| Mar 31, 2025 | 121.81 Mn |
| Dec 31, 2024 | 121.51 Mn |
| Sep 30, 2024 | 121.21 Mn |
| Jun 30, 2024 | 120.92 Mn |
| Mar 31, 2024 | 120.64 Mn |
| Dec 31, 2023 | 120.36 Mn |
| Sep 30, 2023 | 95.09 Mn |
| Jun 30, 2023 | 94.83 Mn |
| Mar 31, 2023 | 72.05 Mn |
| Dec 31, 2022 | 71.88 Mn |
| Sep 30, 2022 | 71.71 Mn |
| Jun 30, 2022 | 71.55 Mn |
| Mar 31, 2022 | 71.38 Mn |
| Dec 31, 2021 | 71.22 Mn |
| Dec 31, 2020 | 74.38 Mn |
| Sep 30, 2020 | 73.97 Mn |